Bioatla Inc (BCAB)

Apr 25, 2025

BioAtla Inc (BCAB) Could Be Worth Considering For The Next Few Weeks - Stocksregister

Apr 25, 2025

Apr 24, 2025

BioAtla announces poster presentations at 2025 AACR meeting - TipRanks

Apr 24, 2025

Apr 24, 2025

How did BioAtla Inc (BCAB) fare last session? - uspostnews.com

Apr 24, 2025

Apr 24, 2025

BCAB’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 24, 2025

Apr 24, 2025

BioAtla (BCAB) to Showcase Innovative Cancer Research at 2025 Co - GuruFocus

Apr 24, 2025

Apr 24, 2025

BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times

Apr 24, 2025

Apr 24, 2025

Cancer Treatment Breakthrough: BioAtla's Novel Drug Outperforms Standard Therapy in Multiple Cancers - Stock Titan

Apr 24, 2025

Apr 23, 2025

BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Apr 23, 2025

Apr 23, 2025

BioAtla, Inc. to Present Phase 2 Trial Results of Ozuriftamab Vedotin at ASCO 2025 Annual Meeting - Nasdaq

Apr 23, 2025

Apr 23, 2025

New Phase 2 Cancer Drug Data: BioAtla's Head and Neck Cancer Treatment Results at ASCO 2025 - Stock Titan

Apr 23, 2025

Apr 21, 2025

BioAtla stock holds $1 target, Market Outperform rating By Investing.com - Investing.com Nigeria

Apr 21, 2025

Apr 21, 2025

BioAtla stock holds $1 target, Market Outperform rating - Investing.com Australia

Apr 21, 2025

Apr 14, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 14, 2025

Apr 13, 2025

Norges Bank Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Apr 13, 2025

Apr 08, 2025

BioAtla's SWOT analysis: oncology biotech's stock faces pivotal year - Investing.com

Apr 08, 2025

Apr 08, 2025

BioAtla’s SWOT analysis: oncology biotech’s stock faces pivotal year By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

BioAtla’s SWOT analysis: oncology biotech’s stock faces pivotal year - Investing.com India

Apr 08, 2025

Apr 04, 2025

HC Wainwright Has Optimistic Outlook of BioAtla Q1 Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

FY2029 Earnings Estimate for BioAtla Issued By HC Wainwright - Defense World

Apr 03, 2025

Apr 01, 2025

BioAtla (NASDAQ:BCAB) Given “Neutral” Rating at HC Wainwright - Defense World

Apr 01, 2025

Mar 31, 2025

BioAtla stock price target cut to $1 by Citizens JMP - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

BioAtla price target lowered to $1 from $5 at Citizens JMP - TipRanks

Mar 31, 2025

Mar 29, 2025

BioAtla, Inc. (NASDAQ:BCAB) Q4 2024 Earnings Call Transcript - MSN

Mar 29, 2025

Mar 29, 2025

Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky - Yahoo Finance

Mar 29, 2025

Mar 28, 2025

BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook - TipRanks

Mar 28, 2025

Mar 28, 2025

BioAtla stock price target cut to $10 at BTIG, retains Buy rating - Investing.com Canada

Mar 28, 2025

Mar 28, 2025

BioAtla stock price target cut to $10 at BTIG, retains Buy rating By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

BioAtla Inc. (BCAB) reports earnings - Quartz

Mar 28, 2025

Mar 28, 2025

BioAtla, Inc. SEC 10-K Report - TradingView

Mar 28, 2025

Mar 28, 2025

BioAtla Inc: Weathering Stock Market Storms with 22.78M Market Cap - investchronicle.com

Mar 28, 2025

Mar 27, 2025

BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: BioAtla Q4 2024 sees strategic cost cuts, stock rises By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: BioAtla Q4 2024 sees strategic cost cuts, stock rises - Investing.com India

Mar 27, 2025

Mar 27, 2025

BioAtla announces restructuring, to cut over 30% of workforce - TipRanks

Mar 27, 2025

Mar 27, 2025

BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year - TipRanks

Mar 27, 2025

Mar 27, 2025

Bioatla IncAnnounces 30% Workforce Reduction - MarketScreener

Mar 27, 2025

Mar 27, 2025

BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress - The Manila Times

Mar 27, 2025

Mar 26, 2025

Earnings Outlook For BioAtla - Benzinga

Mar 26, 2025

Mar 20, 2025

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings - Quantisnow

Mar 20, 2025

Mar 20, 2025

BioAtla, Inc. Announces Abstract Presentations at European Lung Cancer Congress and Mayo Clinic Symposium 2025 - Nasdaq

Mar 20, 2025

Mar 19, 2025

BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025 - Quantisnow

Mar 19, 2025